login
login

Europe Daily Bulletin No. 13062

15 November 2022
Contents Publication in full By article 32 / 39
EU RESPONSE TO COVID-19 / Health
European Commission authorises a seventh Covid-19 vaccine, VidPrevtyn Beta, developed by Sanofi and GSK
Brussels, 14/11/2022 (Agence Europe)

The European Commission authorised, on 10 November, a seventh vaccine against Covid-19: VidPrevtyn Beta. This vaccine was developed by Sanofi and GSK. The European Commission’s formal decision is based on a positive recommendation from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), issued the same day. VidPrevtyn Beta is a recombinant protein vaccine formulated with the Beta variant antigen and adjuvanted with GSK’s pandemic adjuvant.

Contents

Russian invasion of Ukraine
EXTERNAL ACTION
SECTORAL POLICIES
INSTITUTIONAL
FUNDAMENTAL RIGHTS - SOCIETAL ISSUES
ECONOMY - FINANCE - BUSINESS
EU RESPONSE TO COVID-19
NEWS BRIEFS
Kiosk